DiaMedica Therapeutics Inc.DMAC

Market cap

$356.36M

P/E ratio

	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	-	4	7	5	5	5	3
Marketable securities, current	-	4	20	40	29	48	41
Total cash & short-term investments	-	8	28	45	34	53	44
Accounts receivable, net	1	1	0	0	0	0	0
Total current assets	18	9	28	45	34	54	45
Property, plant and equipment, net	0	0	0	0	0	0	0
Total non-current assets	0	0	0	0	1	0	2
Total assets	18	9	28	46	34	54	46
Accounts payable	-	0	1	1	1	1	1
Total current liabilities	1	1	2	2	2	3	5
Total non-current liabilities	0	0	0	0	0	0	0
Common stock and paid-in capital	63	64	95	127	128	167	181
Retained earnings	-46	-57	-69	-82	-96	-116	-140
Stockholders' equity	17	8	26	44	32	51	41